OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
600560 Beijing Aritime Intelligent Control
- 16.03
- +0.20+1.26%
Trading Apr 1 13:36 CST
3.59BMarket Cap68.21P/E (TTM)
16.17High15.84Low32.93KlotVolume15.84Open15.83Pre Close52.84MTurnover1.47%Turnover Ratio68.21P/E (Static)223.65MShares22.4852wk High3.80P/B3.59BFloat Cap10.8852wk Low17.41Limit Up223.65MShs Float31.79Historical High14.25Limit Down2.09%Amplitude1.00Historical Low0.07Dividend TTM16.05Avg Price16.29KlotAsk0.44%Div YieldTTM100Lot Size16.05KlotBid
Beijing Aritime Intelligent Control Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -22.13%739.42M | -27.73%482.63M | -25.54%289.05M | -35.08%140.52M | 29.16%949.58M | 45.75%667.83M | 31.22%388.2M | 38.69%216.46M | 4.02%735.2M | -8.81%458.22M |
| Operating revenue | -22.13%739.42M | -27.73%482.63M | -25.54%289.05M | -35.08%140.52M | 29.16%949.58M | 45.75%667.83M | 31.22%388.2M | 38.69%216.46M | 4.02%735.2M | -8.81%458.22M |
| Other operating revenue | -21.26%11.85M | ---- | 1.51%7.58M | ---- | 56.77%15.05M | ---- | -5.91%7.47M | ---- | -41.66%9.6M | ---- |
| Total operating cost | -26.19%650.58M | -28.42%446.29M | -26.73%266.63M | -35.05%129M | 27.04%881.37M | 48.57%623.5M | 36.39%363.9M | 41.87%198.61M | 4.41%693.79M | -9.22%419.67M |
| Operating cost | -30.93%532.13M | -33.64%360.35M | -31.93%213.38M | -39.46%105.38M | 34.09%770.41M | 57.72%543.03M | 42.55%313.47M | 47.55%174.06M | 7.34%574.55M | -11.49%344.31M |
| Operating tax surcharges | 4.56%7.21M | 32.18%5.18M | -18.26%2.73M | -69.06%358.06K | -2.00%6.9M | -20.71%3.92M | 7.57%3.34M | 152.59%1.16M | -30.41%7.04M | 28.40%4.94M |
| Operating expense | 19.68%26M | 5.68%16.51M | -7.75%10M | -12.98%4.85M | -2.12%21.72M | 20.68%15.62M | 36.62%10.84M | 19.16%5.58M | -13.10%22.19M | -3.41%12.94M |
| Administration expense | -5.17%42.2M | 3.11%30.81M | 5.10%20.12M | 20.22%11.24M | 10.14%44.5M | 13.72%29.88M | 16.56%19.15M | 12.66%9.35M | -0.98%40.4M | 18.12%26.27M |
| Financial expense | 38.90%-2.91M | 27.61%-2.58M | 16.90%-2.05M | 4.63%-1.19M | 21.47%-4.76M | 18.27%-3.56M | 11.15%-2.46M | 5.09%-1.25M | -108.89%-6.06M | -212.03%-4.36M |
| -Interest expense (Financial expense) | -66.73%26.89K | ---- | ---- | ---- | --80.8K | ---- | ---- | ---- | --0 | ---- |
| -Interest Income (Financial expense) | 37.83%-3.11M | 25.44%-2.78M | 13.23%-2.19M | 8.02%-1.16M | 21.02%-5M | 17.69%-3.73M | 12.56%-2.52M | 7.67%-1.26M | -96.42%-6.33M | -150.86%-4.53M |
| Research and development | 7.88%45.95M | 4.09%36.03M | 14.67%22.44M | -13.93%8.36M | -23.48%42.6M | -2.67%34.61M | -11.88%19.57M | -1.90%9.71M | 0.03%55.67M | 1.06%35.56M |
| Credit Impairment Loss | -150.02%-37.37M | 158.40%3.92M | -9.80%-6.57M | ---- | -1,560.04%-14.95M | -1,485.55%-6.7M | -1,349.28%-5.98M | ---- | -107.43%-900.42K | -93.36%483.84K |
| Asset Impairment Loss | -20.60%-3.37M | 160.76%89.6K | 138.31%332.45K | ---- | -156.13%-2.79M | -104.19%-147.46K | -182.30%-867.84K | ---- | 131.47%4.97M | 142.04%3.52M |
| Other net revenue | -218.76%-30.67M | 476.76%7.45M | 27.92%-3.71M | 441.22%1.34M | -196.37%-9.62M | -125.40%-1.98M | -220.81%-5.14M | -84.05%248.18K | 19.67%9.98M | 149.94%7.79M |
| Fair value change income | 126.32%695.5 | -240.00%-2.36K | -111.11%-5.29K | ---1.53K | 62.75%-2.64K | 90.38%-695.5 | 0.00%-2.5K | ---- | -183.61%-7.09K | -149.52%-7.23K |
| Invest income | 0.30%1.64M | 7.74%1.67M | 2,817.31%1.59M | 3,155.38%992.85K | 269.71%1.63M | 662.92%1.55M | -77.47%54.6K | -85.05%30.5K | -78.01%441.85K | -82.31%202.83K |
| Asset deal income | 58,877.51%1.39M | ---39.3K | ---3.85K | ---- | --2.35K | ---- | ---- | ---- | ---- | 121.09%3.48K |
| Other revenue | 8.65%7.05M | -45.19%1.82M | -42.83%947.21K | 61.65%351.88K | 18.46%6.49M | -7.31%3.33M | -33.20%1.66M | -83.91%217.68K | -45.39%5.47M | 17.63%3.59M |
| Adjusted Items effecting operating profit | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -0.72%58.17M | 3.39%43.79M | -2.34%18.71M | -28.97%12.85M | 14.01%58.59M | -8.59%42.35M | -42.45%19.15M | 2.62%18.1M | 1.47%51.39M | 6.97%46.34M |
| Add:Non operating Income | 248.91%2.39M | 285.83%1.41M | 283.43%1.4M | 1,381.92%1.4M | 10,619.76%684.1K | 3,222.54%366.11K | 3,208.62%364.58K | --94.33K | -99.34%6.38K | -98.88%11.02K |
| Less:Non operating expense | -47.97%69.95K | 3,925.48%2.72M | -63.64%17.3K | 351.64%17.3K | -91.79%134.44K | -95.78%67.59K | -97.02%47.58K | -99.76%3.83K | 519.75%1.64M | -40.72%1.6M |
| Total profit | 2.28%60.49M | -0.40%42.48M | 3.16%20.09M | -21.73%14.24M | 18.85%59.14M | -4.68%42.65M | -38.56%19.47M | 13.36%18.19M | -3.09%49.76M | 7.56%44.75M |
| Less:Income tax cost | -16.95%3.16M | -31.78%1.8M | -123.92%-248.41K | -34.91%1.09M | 110.82%3.81M | -46.62%2.63M | -74.77%1.04M | -11.61%1.67M | -37.32%1.81M | -5.68%4.94M |
| Add:Adjusted items effecting net profit | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit | 3.60%57.33M | 1.67%40.69M | 10.32%20.34M | -20.40%13.15M | 15.39%55.34M | 0.52%40.02M | -33.16%18.43M | 16.70%16.51M | -1.06%47.96M | 9.47%39.81M |
| Net profit from continuing operation | 3.60%57.33M | 1.67%40.69M | 10.32%20.34M | -20.40%13.15M | 15.39%55.34M | 0.52%40.02M | -33.16%18.43M | 16.70%16.51M | -1.06%47.96M | 9.47%39.81M |
| Less:Minority Profit | 66.82%4.72M | 3.01%2.46M | 171.98%1.92M | 160.10%1.37M | -28.10%2.83M | 33.98%2.39M | -50.01%705.57K | -12.90%527.48K | 79.77%3.94M | 21.52%1.78M |
| Net profit of parent company owners | 0.19%52.61M | 1.58%38.23M | 3.88%18.42M | -26.35%11.77M | 19.27%52.51M | -1.05%37.63M | -32.25%17.73M | 18.03%15.99M | -4.88%44.02M | 8.96%38.03M |
| Earning per share | ||||||||||
| Basic earning per share | 0.00%0.235 | 0.00%0.17 | 3.78%0.0823 | -28.57%0.05 | 19.29%0.235 | 0.00%0.17 | -32.22%0.0793 | 16.67%0.07 | -4.83%0.197 | 6.25%0.17 |
| Diluted earning per share | 0.00%0.235 | 0.00%0.17 | 3.78%0.0823 | -28.57%0.05 | 19.29%0.235 | 0.00%0.17 | -32.22%0.0793 | 16.67%0.07 | -4.83%0.197 | 6.25%0.17 |
| Other composite income | 41.54%-1.04M | |||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 34.84%-1.11M | ---- |
| Other composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%72.34K | ---- |
| Total composite income | 3.60%57.33M | 1.67%40.69M | 10.32%20.34M | -20.40%13.15M | 17.95%55.34M | 0.52%40.02M | -33.16%18.43M | 16.70%16.51M | 0.49%46.91M | 9.47%39.81M |
| Total composite income of parent company owners | 0.19%52.61M | 1.58%38.23M | 3.88%18.42M | -26.35%11.77M | 22.37%52.51M | -1.05%37.63M | -32.25%17.73M | 18.03%15.99M | -3.73%42.91M | 8.96%38.03M |
| Total composite income of minority owners | 66.82%4.72M | 3.01%2.46M | 171.98%1.92M | 160.10%1.37M | -29.40%2.83M | 33.98%2.39M | -50.01%705.57K | -12.90%527.48K | 89.33%4.01M | 21.52%1.78M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.